Matt Hewitt
Stock Analyst at Craig-Hallum
(3.43)
# 909
Out of 4,868 analysts
43
Total ratings
51.35%
Success rate
4.72%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $45 → $36 | $18.08 | +99.12% | 8 | Jun 13, 2025 | |
| CSBR Champions Oncology | Maintains: Buy | $8 → $12 | $8.26 | +45.28% | 4 | Mar 12, 2025 | |
| CLOV Clover Health Investments | Initiates: Buy | $6 | $2.97 | +102.02% | 1 | Dec 17, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $21.56 | +48.42% | 4 | Nov 13, 2024 | |
| OMCL Omnicell | Maintains: Buy | $45 → $64 | $28.27 | +126.39% | 6 | Oct 31, 2024 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $135 → $140 | $114.64 | +22.12% | 3 | Jul 9, 2024 | |
| NOTV Inotiv | Maintains: Buy | $25 → $10 | $2.17 | +360.83% | 3 | May 16, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $35 → $30 | $21.05 | +42.52% | 3 | May 2, 2024 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $2.11 | +231.75% | 1 | Nov 29, 2023 | |
| RGEN Repligen | Maintains: Buy | $207 → $200 | $117.54 | +70.15% | 3 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.65 | +506.06% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $67 → $30 | $7.01 | +327.96% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $0.98 | +40,716.33% | 1 | Jan 4, 2022 |
Simulations Plus
Jun 13, 2025
Maintains: Buy
Price Target: $45 → $36
Current: $18.08
Upside: +99.12%
Champions Oncology
Mar 12, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $8.26
Upside: +45.28%
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $2.97
Upside: +102.02%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30 → $32
Current: $21.56
Upside: +48.42%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45 → $64
Current: $28.27
Upside: +126.39%
Ligand Pharmaceuticals
Jul 9, 2024
Maintains: Buy
Price Target: $135 → $140
Current: $114.64
Upside: +22.12%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25 → $10
Current: $2.17
Upside: +360.83%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35 → $30
Current: $21.05
Upside: +42.52%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $2.11
Upside: +231.75%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $117.54
Upside: +70.15%
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $1.65
Upside: +506.06%
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $7.01
Upside: +327.96%
Jan 4, 2022
Initiates: Buy
Price Target: $400
Current: $0.98
Upside: +40,716.33%